Aromatase Inhibitors Reduce the Expression of a Hypoxia Metagene in Oestrogen Receptor Positive Breast Cancer in Postmenopausal Women.

被引：0
|
作者：
Ghazoui, Z.
Buffa, F. M.
Dunbier, A. K.
Anderson, H.
Dexter, T.
Smith, I. E.
Harris, A. L.
Dowsett, M.
机构：
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] Breakthrough Breast Canc Res Ctr, London, England
[3] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：518S / 518S
页数：1
相关论文
共 50 条
  • [31] Selective oestrogen receptor modulators, aromatase inhibitors and the female breast
    Howell, A
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2005, 17 (04) : 429 - 434
  • [32] Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor-positive breast cancer patients: upfront or sequential?
    Dediu, M.
    Median, D.
    Alexandru, A.
    Vremes, G.
    Gal, C.
    Gongu, M.
    JOURNAL OF BUON, 2009, 14 (03): : 375 - 379
  • [33] In postmenopausal women with breast cancer treated with aromatase inhibitors, denosumab reduced fractures
    Wilcken, Nicholas
    Lee, Clara Inkyung
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
  • [34] Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women
    不详
    Drugs & Therapy Perspectives, 2009, 25 (10) : 23 - 26
  • [35] The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women
    Mouridsen, HT
    Robert, NJ
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (12) : 1678 - 1689
  • [36] Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer
    Ligibel, Jennifer A.
    Winer, Eric P.
    WOMENS HEALTH, 2006, 2 (01) : 89 - 97
  • [37] Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial
    A Barnadas
    M Gil
    S González
    I Tusquets
    M Muñoz
    A Arcusa
    L Prieto
    M Margelí-Vila
    A Moreno
    British Journal of Cancer, 2009, 100 : 442 - 449
  • [38] Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial
    Barnadas, A.
    Gil, M.
    Gonzalez, S.
    Tusquets, I.
    Munoz, M.
    Arcusa, A.
    Prieto, L.
    Margeli-Vila, M.
    Moreno, A.
    BRITISH JOURNAL OF CANCER, 2009, 100 (03) : 442 - 449
  • [39] Extended Aromatase Inhibitors in Hormone-Receptor-Positive Breast Cancer
    Goodwin, Pamela J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 462 - 463
  • [40] Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters
    Borreani, Claudia
    Alfieri, Sara
    Infante, Gabriele
    Miceli, Rosalba
    Mariani, Paola
    Bosisio, Marco
    Vernieri, Claudio
    Bianchi, Giulia, V
    Capri, Giuseppe
    ONCOLOGY, 2021, 99 (02) : 84 - 95
12345